Zoster vaccine (Zostavax®): a guide to its use in preventing herpes zoster and postherpetic neuralgia

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.7, 2011-07, pp. : 1-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoster Vaccine (Zostavax®): A Review of its Use in Preventing Herpes Zoster and Postherpetic Neuralgia in Older Adults

By Sanford Mark Keating Gillian M.

Drugs & Aging, Vol. 27, Iss. 2, 2010-02 ,pp. : 159-176

Adis International

Access to resources Recommend Favorite

VZV vaccine reduces herpes zoster, postherpetic neuralgia in elderly

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Management of herpes zoster (shingles) and postherpetic neuralgia

By Johnson Robert W Whitton Tessa L

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 551-559

Informa Healthcare

Access to resources Recommend Favorite

Herpes Zoster and Postherpetic Neuralgia: Optimizing Management in the Elderly Patient

By Johnson Robert W.

Drugs & Aging, Vol. 25, Iss. 12, 2008-01 ,pp. : 991-1006

Adis International

Access to resources Recommend Favorite

The clinical significance of infrared thermography for the prediction of postherpetic neuralgia in acute herpes zoster patients

SKIN RESEARCH AND TECHNOLOGY, Vol. 22, Iss. 1, 2016-02 ,pp. : 108-114

John Wiley & Sons Inc

Access to resources Recommend Favorite